Apex Hospitex And Neuroscience Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
- Paid Up Capital ₹ 6.44 Cr
- Company Age 22 Year, 9 Months
- Last Filing with ROC 01 Oct 2018
- Revenue Growth 17.69%
- Profit Growth 6.64%
- Ebitda 23.35%
- Net Worth 10.23%
- Total Assets 7.87%
About Apex Hospitex And Neuroscience
Apex Hospitex And Neuroscience Limited (AHANL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 April 2002 and has a history of 22 years and nine months. Its registered office is in Kolkata, West Bengal, India.
The Corporate was formerly known as Apex Hospitex And Neuroscience Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 01 October 2018. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 6.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110WB2002PLC094561
- Company No.
094561
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2002
- Date of AGM
26 Aug 2018
- Date of Balance Sheet
01 Oct 2018
- Listing Status
Unlisted
- ROC Code
Roc-Kolkata
Industry
Who are the key members and board of directors at Apex Hospitex And Neuroscience?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Apex Hospitex And Neuroscience.
Apex Hospitex And Neuroscience Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 17.69% increase. The company also saw a slight improvement in profitability, with a 6.64% increase in profit. The company's net worth Soared by an impressive increase of 10.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Hospitex And Neuroscience?
In 2017, Apex Hospitex And Neuroscience had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apex Hospitex And Neuroscience?
Apex Hospitex And Neuroscience has a workforce of 189 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Hospitex And Neuroscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Hospitex And Neuroscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
